KMT2A and acute myeloid leukemia: Previously, Christiansen et al. described three cases of BRAF V600E-mutant AML, all of which occurred secondary to cytotoxic therapy, exhibited monocytic morphology, and harbored t(9;11)(p22;q23) KMT2A rearrangements [4].